JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265095

Human AP1M2 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

AP1M2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1.

View Alternative Names

AP-1 complex subunit mu-2, AP-mu chain family member mu1B, AP1M2_HUMAN, AP47 2, Adaptor protein complex AP-1 mu-2 subunit, Adaptor-related protein complex 1 mu-2 subunit, Clathrin assembly protein complex 1 medium chain 2, Golgi adaptor HA1/AP1 adaptin mu-2 subunit, HA1 47 kDa subunit 2, HSMU1B, MU 1B, Mu-adaptin 2, Mu1B-adaptin

1 Images
Sanger Sequencing - Human AP1M2 knockout HeLa cell line (AB265095)
  • Sanger seq

Unknown

Sanger Sequencing - Human AP1M2 knockout HeLa cell line (AB265095)

Homozygous : 1 bp insertion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265095-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265095 Human AP1M2 knockout HeLa cell line", "number":"AB265095-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265095-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265095 Human AP1M2 knockout HeLa cell line", "number":"AB265095-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
AP1M2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

AP1M2 or Adaptor Protein Complex 1 Mu 2 Subunit is an essential component of the adaptor protein complex involved in clathrin-mediated endocytosis. It exhibits a molecular weight of approximately 47 kDa. AP1M2 is ubiquitously expressed in human tissues with prominent expression in the brain liver and kidney. Its role as a cytosolic protein links it to cellular transport and sorting mechanisms.
Biological function summary

AP1M2 interacts with other subunits to form the AP-1 complex a critical assembly for sorting lysosomal enzymes and trans-Golgi network system function. The AP-1 complex directs the budding of vesicles by interacting with clathrin and cargo membrane proteins. These interactions ensure proper intracellular trafficking contributing to the maintenance of cellular homeostasis. AP1M2's interactions within the complex indicate its indispensable role in proper membrane protein sorting.

Pathways

AP1M2 contributes significantly to the endocytic pathway and protein transport processes. It is active within the clathrin-mediated endocytosis pathway working closely with proteins such as AP1B1 and AP1G1. These partnerships facilitate the transport of essential molecules from the trans-Golgi network to endosomes and lysosomes influencing cell signaling and nutrient uptake.

AP1M2's dysfunction relates to neurodegenerative conditions such as Alzheimer's disease where disruptions in protein sorting and trafficking are common. It also connects to lysosomal storage disorders as abnormalities in the AP-1 complex affect lysosome function and enzyme transport. AP1M2 through its roles and associations suggests its involvement alongside other proteins such as APP and lysosomal enzymes in disease mechanisms.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com